Anika Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||
| – | 21.1 | 13.8 | – | 45.1 | – | – | 127.3 | 9.4 | 22.7 | 32.2 | 27.7 | 9.5 | 23.8 | 21.2 | 15.9 | 12.1 | 27.5 | 16.2 | 19.0 | 22.8 | 25.5 | 26.4 | 27.4 | – | 126.7 | – | – | – | – | |
| 15.3 | 5.8 | 4.3 | 5.4 | 0.5 | 0.9 | 0.7 | 6.8 | 4.0 | 4.5 | 5.5 | 5.4 | 1.0 | 2.2 | 1.6 | 2.1 | 2.0 | 7.5 | 5.9 | 6.3 | 7.2 | 7.2 | 4.7 | 6.5 | 4.9 | 3.5 | 2.8 | 2.8 | 2.0 | 1.2 | |
| 3.7 | 2.7 | 2.0 | 2.8 | 0.3 | 0.5 | 0.6 | 5.9 | 3.5 | 3.5 | 3.3 | 3.0 | 0.6 | 1.1 | 1.1 | 1.4 | 1.3 | 4.2 | 3.5 | 2.8 | 3.3 | 3.1 | 1.9 | 2.6 | 2.4 | 1.8 | 1.5 | 1.6 | 1.6 | 1.0 | |
| – | – | – | – | – | – | 0.0 | 6.0 | – | – | 3.8 | 4.3 | 0.2 | 1.9 | 1.4 | 1.7 | 1.5 | 6.7 | 4.9 | 5.1 | 6.2 | 6.0 | – | 5.1 | 4.2 | 2.9 | 2.2 | 2.2 | 1.6 | 0.7 | |
| – | – | – | – | – | – | – | 57.4 | – | – | 17.7 | 18.1 | 1.3 | 7.0 | 7.0 | 6.1 | 4.0 | 15.7 | 7.9 | 9.1 | 11.7 | 13.6 | – | 14.7 | – | – | – | 15.3 | 35.3 | – | |
| – | 30.3 | 49.5 | – | – | – | 40.5 | 59.9 | 4.5 | 27.6 | 213.4 | – | – | – | 18.0 | 15.4 | 15.7 | 22.9 | 16.2 | 19.6 | 75.7 | 25.5 | 16.3 | 21.8 | 56.3 | 161.0 | – | – | – | 31.6 | |
| -6.0% | 3.3% | 2.0% | -1.2% | -30.5% | -52.6% | 2.5% | 1.7% | 22.2% | 3.6% | 0.5% | -6.1% | -37.3% | -1.0% | 5.5% | 6.5% | 6.4% | 4.4% | 6.2% | 5.1% | 1.3% | 3.9% | 6.1% | 4.6% | 1.8% | 0.6% | -0.7% | -2.2% | -1.0% | 3.2% | |
| Margins | ||||||||||||||||||||||||||||||
| 41.7% | 63.3% | 62.6% | 60.7% | 46.9% | 27.3% | 38.5% | 48.0% | 62.4% | 62.6% | 58.6% | 61.5% | 63.1% | 65.9% | 57.1% | 58.7% | 59.4% | 69.7% | 80.2% | 77.4% | 76.8% | 75.9% | 70.4% | 74.9% | 52.9% | 56.1% | 59.9% | 68.3% | 63.4% | 56.6% | |
| -225.0% | 26.7% | 23.0% | -0.7% | -6.0% | -65.5% | -24.8% | 3.9% | 24.1% | 28.7% | 20.2% | 21.4% | 11.8% | 13.9% | 13.6% | 21.6% | 27.6% | 43.4% | 58.2% | 51.8% | 49.0% | 40.3% | 20.6% | 29.9% | -21.7% | 1.8% | -12.4% | 0.7% | -4.3% | -9.8% | |
| -225.0% | 27.5% | 30.9% | -18.5% | 1.1% | -59.7% | -23.1% | 5.4% | 42.3% | 19.8% | 17.2% | 19.6% | 10.1% | 9.2% | 7.8% | 13.1% | 16.5% | 27.4% | 36.3% | 33.1% | 31.5% | 28.1% | 17.7% | 23.7% | -18.4% | 2.8% | -9.5% | -68.4% | -47.0% | -9.6% | |
| -91.7% | 19.2% | 8.6% | -6.7% | -14.6% | -46.2% | 1.8% | 11.4% | 88.2% | 16.3% | 2.6% | -33.3% | -35.9% | -2.2% | 9.1% | 13.5% | 12.7% | 32.9% | 36.4% | 32.1% | 9.5% | 28.1% | 28.7% | 29.8% | 8.8% | 2.2% | -2.0% | -6.0% | -1.9% | 3.9% | |
| Returns | ||||||||||||||||||||||||||||||
| -54.0% | 12.6% | 14.4% | -9.7% | 0.6% | -33.6% | -17.8% | 4.6% | 36.9% | 15.6% | 10.1% | 11.0% | 6.0% | 4.5% | 5.1% | 8.9% | 10.8% | 15.2% | 21.5% | 14.6% | 14.6% | 12.1% | 7.1% | 9.4% | -8.8% | 1.4% | -5.2% | -38.9% | -36.6% | -7.6% | |
| -39.1% | 11.5% | 13.3% | -7.7% | 0.6% | -29.5% | -15.1% | 3.8% | 18.8% | 9.4% | 6.8% | 7.6% | 3.8% | 2.8% | 3.3% | 6.4% | 8.3% | 13.2% | 19.8% | 13.0% | 13.5% | 11.3% | 6.7% | 8.2% | -6.6% | 1.2% | -4.3% | -30.5% | -27.8% | -5.7% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||
| – | – | – | – | – | – | -9.3 | -13 | – | – | -46 | -33 | -27 | -10 | -15 | -25 | -34 | -63 | -100 | -111 | -104 | -133 | – | -156 | -94 | -93 | -84 | -67 | -54 | -55 | |
| – | – | – | – | – | – | – | -8.3 | – | – | -7.8 | -4.5 | -4.8 | -0.9 | -1.4 | -1.4 | -1.3 | -2.0 | -1.5 | -2.1 | -1.9 | -2.7 | – | -3.9 | – | – | – | -3.9 | -10.0 | – | |
| 72.5% | 91.3% | 92.3% | 79.1% | 92.2% | 87.7% | 85.0% | 82.2% | 51.0% | 60.5% | 66.8% | 69.1% | 63.4% | 62.8% | 66.1% | 71.3% | 76.7% | 86.9% | 91.8% | 89.4% | 92.7% | 93.2% | 94.5% | 87.2% | 74.5% | 82.6% | 81.8% | 78.4% | 76.0% | 75.4% | |
| – | – | – | – | – | – | 0.1 | 0.1 | – | – | 0.0 | 0.1 | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||
| -0.56 | 0.44 | 0.39 | -0.24 | 0.02 | -0.68 | -0.31 | 0.08 | 0.98 | 0.52 | 0.41 | 0.53 | 0.32 | 0.32 | 0.32 | 0.62 | 0.82 | 1.39 | 2.51 | 2.01 | 2.15 | 2.11 | 1.27 | 1.89 | -1.69 | 0.28 | -1.02 | -5.64 | -3.83 | -0.76 | |
| 0.25 | 1.60 | 1.26 | 1.32 | 1.63 | 1.14 | 1.33 | 1.42 | 2.32 | 2.61 | 2.41 | 2.69 | 3.12 | 3.47 | 4.07 | 4.71 | 4.97 | 5.06 | 6.92 | 6.07 | 6.84 | 7.53 | 7.19 | 7.97 | 9.17 | 10.10 | 10.73 | 8.24 | 8.15 | 7.87 | |
| 1.04 | 3.49 | 2.72 | 2.51 | 2.66 | 2.02 | 1.72 | 1.66 | 2.66 | 3.32 | 4.08 | 4.80 | 5.30 | 7.10 | 6.24 | 6.89 | 7.59 | 9.15 | 11.66 | 13.76 | 14.74 | 17.49 | 17.95 | 20.06 | 19.15 | 19.62 | 19.61 | 14.48 | 10.46 | 10.01 | |
| -0.23 | 0.31 | 0.11 | -0.09 | -0.24 | -0.53 | 0.02 | 0.16 | 2.04 | 0.42 | 0.06 | -0.90 | -1.12 | -0.08 | 0.37 | 0.64 | 0.63 | 1.67 | 2.52 | 1.95 | 0.65 | 2.11 | 2.06 | 2.38 | 0.80 | 0.22 | -0.21 | -0.49 | -0.16 | 0.30 | |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.